Aclaris Therapeutics, Inc. Skyrocketed
Mon, Nov 18, 2024 at 07:36 PM
Aclaris Therapeutics, Inc. (ACRS:NASDAQ) jumped higher at $3.14, a gain of 53.2%. On Mon, Nov 18, 2024, ACRS:NASDAQ hit a New 2-Week High of $3.14. The stock appeared on our News Catalysts scanner on Mon, Nov 18, 2024 at 09:47 AM in the 'AGREEMENT' category. From Mon, Nov 04, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days
About Aclaris Therapeutics, Inc. (ACRS:NASDAQ)
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
Top 10 Gainers:
- HCW Biologics Inc. (HCWB:NASDAQ), 310.73%
- SRAX, Inc. (SRAX:NASDAQ), 194.12%
- Bakkt Holdings Inc. Class A (BKKT:NYSE), 162.46%
- Apollomics Inc. (APLM:NASDAQ), 102.51%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 53.17%
- Sintx Technologies, Inc. (SINT:NASDAQ), 52.88%
- Jowell Global Ltd. (JWEL:NASDAQ), 48.21%
- Eco Wave Power Global AB (publ) (WAVE:NASDAQ), 43.75%
- Alpha Technology Group Limited (ATGL:NASDAQ), 38%
- Streamline Health Solutions, Inc. (STRM:NASDAQ), 37.83%